id:"swepub:oai:lup.lub.lu.se:94b3a0ac-b57b-4f7c-90b0-78338e3d9b86"
Search: id:"swepub:oai:lup.lub.lu.se:94b3a0ac-b57b-4f7c-90b0-78338e3d9b86" > Comparison of the A...
- 1 of 1
- Previous record
- Next record
- To hitlist
Comparison of the ADNEX and ROMA risk prediction models for the diagnosis of ovarian cancer : a multicentre external validation in patients who underwent surgery
-
- Landolfo, Chiara (author)
- Catholic University of Leuven,Policlinico Universitario Agostino Gemelli,Queen Charlotte's and Chelsea Hospital
-
- Ceusters, Jolien (author)
- Catholic University of Leuven
-
- Valentin, Lil (author)
- Lund University,Lunds universitet,Obstetrisk, gynekologisk och prenatal ultraljudsdiagnostik,Forskargrupper vid Lunds universitet,Obstetric, Gynaecological and Prenatal Ultrasound Research,Lund University Research Groups,Skåne University Hospital
- show more...
- show less...
- (creator_code:org_t)
- English.
- In: British Journal of Cancer. - 0007-0920.
- Journal article (peer-reviewed)
Abstract
Subject headings
Close
- Background: Several diagnostic prediction models to help clinicians discriminate between benign and malignant adnexal masses are available. This study is a head-to-head comparison of the performance of the Assessment of Different NEoplasias in the adneXa (ADNEX) model with that of the Risk of Ovarian Malignancy Algorithm (ROMA). Methods: This is a retrospective study based on prospectively included consecutive women with an adnexal tumour scheduled for surgery at five oncology centres and one non-oncology centre in four countries between 2015 and 2019. The reference standard was histology. Model performance for ADNEX and ROMA was evaluated regarding discrimination, calibration, and clinical utility. Results: The primary analysis included 894 patients, of whom 434 (49%) had a malignant tumour. The area under the receiver operating characteristic curve (AUC) was 0.92 (95% CI 0.88–0.95) for ADNEX with CA125, 0.90 (0.84–0.94) for ADNEX without CA125, and 0.85 (0.80–0.89) for ROMA. ROMA, and to a lesser extent ADNEX, underestimated the risk of malignancy. Clinical utility was highest for ADNEX. ROMA had no clinical utility at decision thresholds <27%. Conclusions: ADNEX had better ability to discriminate between benign and malignant adnexal tumours and higher clinical utility than ROMA. Clinical trial registration: clinicaltrials.gov NCT01698632 and NCT02847832.
Subject headings
- MEDICIN OCH HÄLSOVETENSKAP -- Klinisk medicin -- Reproduktionsmedicin och gynekologi (hsv//swe)
- MEDICAL AND HEALTH SCIENCES -- Clinical Medicine -- Obstetrics, Gynaecology and Reproductive Medicine (hsv//eng)
Publication and Content Type
- art (subject category)
- ref (subject category)
Find in a library
- British Journal of Cancer (Search for host publication in LIBRIS)
To the university's database
- 1 of 1
- Previous record
- Next record
- To hitlist
Find more in SwePub
- By the author/editor
- Landolfo, Chiara
- Ceusters, Jolien
- Valentin, Lil
- Froyman, Wouter
- Van Gorp, Toon
- Heremans, Ruben
- show more...
- Baert, Thaïs
- Wouters, Roxanne
- Vankerckhoven, A ...
- Van Rompuy, Anne ...
- Billen, Jaak
- Moro, Francesca
- Mascilini, Flori ...
- Neumann, Adam
- Van Holsbeke, Ca ...
- Chiappa, Valenti ...
- Bourne, Tom
- Fischerova, Dani ...
- Testa, Antonia
- Coosemans, An
- Timmerman, Dirk
- Van Calster, Ben
- show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
- MEDICAL AND HEAL ...
- and Clinical Medicin ...
- and Obstetrics Gynae ...
- Articles in the publication
- British Journal ...
- By the university
- Lund University
Search outside SwePub
- Extend your search to:
- Google Book Search
- Google Scholar
Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.
- Copyright © LIBRIS - National Library Systems
- LIBRIS.kb.se
